Jan Med India Pharma Private Limited

Jan Med India Pharma Private Limited - chemicals in Erode, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U33100TZ2021PTC037476 Incorporated 03 November 2021 ROC Coimbatore HQ Erode, Tamil Nadu, India
Active Private Limited Company chemicals MSME · Micro
Revenue · FY 2025
₹23.22 Lakh
▲ 70% YoY
Net profit · FY 2025
₹84,848
Net margin 3.7%
EBITDA · FY 2025
₹1.22 Lakh
EBITDA margin 5.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
GST registrations
1
None active

About Jan Med India Pharma Private Limited

Data last updated:

Jan Med India Pharma Private Limited is a private limited company based in Erode, Tamil Nadu, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 03 November 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U33100TZ2021PTC037476. The company has 1 GST registration on record, which is no longer active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Thangaraj Sheela (Managing Director) and Manamohan.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.811P Gandhiji Street, Erode C Kasipalayam, Tamil Nadu, India – 638009.

As per the financials filed for FY 2025, the company reported a revenue of ₹23.22 Lakh, a growth of 70% compared to the previous year. For the same year it recorded a net profit of ₹84,848 (net margin 3.7%) and EBITDA of ₹1.22 Lakh (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 352% over three years.

Jan Med India Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-07-0023507). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U33100TZ2021PTC037476
Registration Number 037476
Incorporation Date 03 November 2021
ROC Coimbatore
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-07-0023507

Recognitions & Rankings of Jan Med India Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-TN-07-0023507

Contact details

Jan Med India Pharma Private Limited's registered office is in Erode, Tamil Nadu. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    No.811P Gandhiji Street, Erode C Kasipalayam, Tamil Nadu, India – 638009
  • Industry
    Chemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products

To see the full contact details of Jan Med India Pharma Private Limited, buy the company report.

Comprehensive company report
Jan Med India Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Jan Med India Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Jan Med India Pharma Private Limited, buy the company report.

Financials of Jan Med India Pharma Private Limited

FY 2024 filings available

Jan Med India Pharma Private Limited reported revenue of ₹23.22 Lakh (up 70% YoY) for FY 2025.

Revenue · FY 2025
₹23.22 Lakh ▲ 70%
Net profit · FY 2025
₹84,848 margin 3.7%
EBITDA · FY 2025
₹1.22 Lakh margin 5.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 352%
EBITDA CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 157%

Revenue has grown at a compounded annual rate (CAGR) of 352% over three years, including 70% growth in the latest year. EBITDA rose 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.22 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹84,848
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin5.2%
Net Profit Margin3.7%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Jan Med India Pharma Private Limited, buy the company report.

Board of directors of Jan Med India Pharma Private Limited

Jan Med India Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Thangaraj SheelaManaging Director03 Nov 20215 Years 0 MonthsCurrent
ManamohanDirector03 Nov 20215 Years 0 MonthsCurrent

Peer comparison

Jan Med India Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Alestra Lifesciences Limited₹24 Lakh (FY 2025)488.0%Kolkata, West Bengal, India
Oram Biochem Private Limited₹23.91 Lakh (FY 2025)Pune, Maharashtra, India
Strelitzia Pharmaceuticals Private Limited₹23.87 Lakh (FY 2025)Ernakulam, Kerala, India
Ista Life Care Private Limited₹23.81 Lakh (FY 2025)124.0%Sangareddy, Telangana, India
Erotas Life Sciences Private Limited₹23.79 Lakh (FY 2025)Hyderabad, Telangana, India
Jan Med India Pharma Private Limitedthis company₹23.22 Lakh (FY 2025)₹84,8483.7%70.0%Erode, Tamil Nadu, India
Terveysliv Pharmaceuticals Private Limited₹23.2 Lakh (FY 2025)Surat, Gujarat, India
Phytoveda Private Limited₹23.17 Lakh (FY 2025)167.0%Mumbai, Maharashtra, India
Deepline Pharma Private Limited₹22.89 Lakh (FY 2025)Delhi, India
Goyal Industrial Park Private Limited₹22.62 Lakh (FY 2024)-40.0%Jaipur, Rajasthan, India
Navante Pharmaceuticals Private Limited₹22.6 Lakh (FY 2025)Vijayawada, Andhra Pradesh, India

To see the full peer comparison of Jan Med India Pharma Private Limited, buy the company report.

Auditor

Jan Med India Pharma Private Limited is audited by V.DEVARAJU & ASSOCIATES for the financial year 2023.

Auditor firmFinancial yearFirm registration number
V.DEVARAJU & ASSOCIATESFY 20230024174S

Shareholding

The shareholding of Jan Med India Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Jan Med India Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Jan Med India Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Jan Med India Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Jan Med India Pharma Private Limited, buy the company report.

Recent activity

Jan Med India Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Manamohan was appointed as Director on 03 Nov 2021.

AGM
Jan Med India Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Jan Med India Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Coimbatore.
Appointed
Manamohan was appointed as Director.
Appointed
Thangaraj Sheela was appointed as Managing Director.
Incorporation
03 Nov 2021
Jan Med India Pharma Private Limited was registered on 03 Nov 2021 with Roc Coimbatore & aged 5 years 16 days as per MCA records.

Frequently asked questions

Jan Med India Pharma is an active private limited company based in Erode, Tamil Nadu, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 03 November 2021 (5+ years old) and is registered under CIN U33100TZ2021PTC037476.

Jan Med India Pharma has 2 current directors:

The latest financial statements of Jan Med India Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2022 are in the company report.

No. Jan Med India Pharma has 1 GST registration on record and it is cancelled or inactive.

The CIN (Corporate Identification Number) of Jan Med India Pharma is U33100TZ2021PTC037476. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jan Med India Pharma was incorporated on 03 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Coimbatore.

The peers of Jan Med India Pharma by revenue are Alestra Lifesciences Limited, Oram Biochem Private Limited, Strelitzia Pharmaceuticals Private Limited, Ista Life Care Private Limited, Erotas Life Sciences Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).

Manamohan was appointed as Director on 03 Nov 2021. Thangaraj Sheela was appointed as Managing Director on 03 Nov 2021.

Yes, Jan Med India Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-07-0023507).

The registered office of Jan Med India Pharma is at No.811P Gandhiji Street, Erode C Kasipalayam, Tamil Nadu, India – 638009.

Jan Med India Pharma operates in the chemicals industry, in the medicinal chemical and botanical products segment.